BioLife Cost Of Revenue from 2010 to 2024

BLFS Stock  USD 27.06  0.29  1.08%   
BioLife Solutions Cost Of Revenue yearly trend continues to be comparatively stable with very little volatility. Cost Of Revenue is likely to outpace its year average in 2024. From the period from 2010 to 2024, BioLife Solutions Cost Of Revenue quarterly data regression had r-value of  0.82 and coefficient of variation of  142.51. View All Fundamentals
 
Cost Of Revenue  
First Reported
1990-09-30
Previous Quarter
13.4 M
Current Value
8.8 M
Quarterly Volatility
7.2 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 1.9 M, Selling General Administrative of 52.9 M or Total Revenue of 150.4 M, as well as many indicators such as Price To Sales Ratio of 4.71, Dividend Yield of 0.0014 or PTB Ratio of 2.0. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Latest BioLife Solutions' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of BioLife Solutions over the last few years. Cost of Revenue is found on BioLife Solutions income statement and represents the costs associated with goods and services BioLife Solutions provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is BioLife Solutions' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

BioLife Cost Of Revenue Regression Statistics

Arithmetic Mean29,770,440
Geometric Mean8,259,253
Coefficient Of Variation142.51
Mean Deviation35,750,292
Median5,186,514
Standard Deviation42,427,055
Sample Variance1800.1T
Range107.7M
R-Value0.82
Mean Square Error639.6T
R-Squared0.67
Significance0.0002
Slope7,765,718
Total Sum of Squares25200.8T

BioLife Cost Of Revenue History

2024101.3 M
202396.5 M
2022107.9 M
202181.4 M
202020.6 M
20198.9 M
20186.2 M

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue96.5 M101.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.